Biomaterial Database

A new selective method for isolation of Haemophilus species. 1997

Z Csukás, and I Cserba

Institute of Microbiology, Semmelweis University Medical School, Budapest, Hungary.

Chocolate agar with teicoplanin disk (30 micrograms) was used for the isolation of Haemophilus strains. Fifty strains of 3 Haemophilus species grew as well in the inhibition zones of teicoplanin disks as on teicoplanin containing selective plates, whereas Gram-positive bacteria failed to form colonies. This selective method proved especially advantageous when Haemophilus strains were isolated from mixed bacterial cultures of 665 specimens.

UI	MeSH Term	Description	Entries
D004352	Drug Resistance, Microbial	The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).	Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006190	Haemophilus	A genus of PASTEURELLACEAE that consists of several species occurring in animals and humans. Its organisms are described as gram-negative, facultatively anaerobic, coccobacillus or rod-shaped, and nonmotile.	Hemophilus
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA.	Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D017334	Teicoplanin	Lipoglycopeptide antibiotic from Actinoplanes teichomyceticus active against gram-positive bacteria. It consists of five major components each with a different fatty acid moiety.	Teichomycin,Targocid,Teichomycin A2

Related Publications

Z Csukás, and I Cserba

New selective medium for the isolation of Haemophilus species.

January 1980, Acta microbiologica Academiae Scientiarum Hungaricae,

Z Csukás, and I Cserba

A selective method for the isolation of Haemophilus in material from the respiratory tract.

January 1969, Acta pathologica et microbiologica Scandinavica,

Z Csukás, and I Cserba

Evaluation of a selective medium for isolation of Haemophilus pleuropneumoniae.

October 1983, Canadian journal of comparative medicine : Revue canadienne de medecine comparee,

Z Csukás, and I Cserba

A selective medium for the isolation of haemophilus from sputum.

October 1969, The Journal of medical laboratory technology,

Z Csukás, and I Cserba

A selective enrichment procedure for the isolation of Haemophilus influenzae.

January 1972, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie,

Z Csukás, and I Cserba

Isolation of Capnocytophaga species with a new selective medium.

September 1985, Journal of clinical microbiology,

Z Csukás, and I Cserba

A selective medium for the primary isolation of Haemophilus pertussis and Haemophilus para-pertussis.

August 1954, Journal of general microbiology,

Z Csukás, and I Cserba

A new method for the selective isolation of phosphoserine-containing peptides.

May 1987, FEBS letters,

Z Csukás, and I Cserba

Optimal bacitracin concentration for selective isolation medium for haemophilus.

July 1971, The American journal of medical technology,